Clinical Trial Update: A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control [Phase 3]

View source ↗

Summary

Pfizer-sponsored Phase 3 trial evaluating the impact of the availability of inhaled insulin on glucose control in diabetes; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Exubera (insulin inhalation powder)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED